Mraz, Amerine & Associates, Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,088 filers reported holding NOVARTIS A G in Q3 2019. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.

Quarter-by-quarter ownership
Mraz, Amerine & Associates, Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$655,062
+0.9%
6,4310.0%0.15%
-2.6%
Q2 2023$648,952
+10.4%
6,431
+0.6%
0.15%
+4.8%
Q1 2023$587,972
+1.4%
6,3910.0%0.14%
+5.8%
Q4 2022$579,792
+19.3%
6,3910.0%0.14%
+5.4%
Q3 2022$486,000
-6.4%
6,391
+4.0%
0.13%
-2.3%
Q2 2022$519,000
-5.3%
6,145
-1.6%
0.13%
+2.3%
Q1 2022$548,000
+0.4%
6,2450.0%0.13%
-7.1%
Q4 2021$546,000
+6.8%
6,2450.0%0.14%0.0%
Q3 2021$511,000
-10.4%
6,2450.0%0.14%
-9.7%
Q2 2021$570,000
+6.7%
6,2450.0%0.16%0.0%
Q1 2021$534,000
-9.5%
6,2450.0%0.16%
-20.9%
Q4 2020$590,000
+8.7%
6,2450.0%0.20%
-3.0%
Q3 2020$543,000
-14.2%
6,245
-13.8%
0.20%
-14.0%
Q2 2020$633,000
+6.0%
7,2450.0%0.24%0.0%
Q1 2020$597,000
-13.7%
7,245
-0.8%
0.24%
+19.3%
Q4 2019$692,000
+9.0%
7,3060.0%0.20%
+4.2%
Q3 2019$635,000
-4.8%
7,3060.0%0.19%
-4.5%
Q2 2019$667,000
-5.0%
7,3060.0%0.20%
-9.2%
Q1 2019$702,000
+12.0%
7,3060.0%0.22%
+4.8%
Q4 2018$627,000
-0.3%
7,3060.0%0.21%
+11.8%
Q3 2018$629,000
+13.9%
7,3060.0%0.19%
+11.4%
Q2 2018$552,000
-6.6%
7,3060.0%0.17%
-10.7%
Q1 2018$591,000
-2.3%
7,306
+1.4%
0.19%
+1.1%
Q4 2017$605,000
-9.7%
7,206
-7.7%
0.18%
-12.7%
Q3 2017$670,000
-8.0%
7,806
-10.5%
0.21%
-6.6%
Q2 2017$728,000
+8.3%
8,7240.0%0.23%
+8.1%
Q1 2017$672,000
+3.4%
8,724
-2.2%
0.21%
+2.9%
Q4 2016$650,000
-7.8%
8,924
-0.0%
0.20%
-15.4%
Q3 2016$705,000
-4.2%
8,9260.0%0.24%
-6.6%
Q2 2016$736,000
+13.8%
8,9260.0%0.26%
+8.4%
Q1 2016$647,000
-15.8%
8,926
+0.0%
0.24%
-18.8%
Q4 2015$768,000
-6.3%
8,9240.0%0.29%
-9.6%
Q3 2015$820,000
-6.6%
8,9240.0%0.32%
-1.5%
Q2 2015$878,000
-0.2%
8,9240.0%0.33%
-0.3%
Q1 2015$880,000
+6.4%
8,9240.0%0.33%
+5.8%
Q4 2014$827,000
-0.8%
8,924
+0.7%
0.31%
-2.8%
Q3 2014$834,000
+6.4%
8,863
+2.4%
0.32%
+5.6%
Q2 2014$784,000
+14.5%
8,658
+7.5%
0.30%
+6.3%
Q1 2014$685,000
+1.0%
8,056
-4.5%
0.29%
-5.3%
Q4 2013$678,000
+4.8%
8,4340.0%0.30%
-2.9%
Q3 2013$647,000
+5.4%
8,434
-2.9%
0.31%
-0.3%
Q2 2013$614,0008,6840.31%
Other shareholders
NOVARTIS A G shareholders Q3 2019
NameSharesValueWeighting ↓
EXENCIAL WEALTH ADVISORS, LLC 188,514$13,713,0005.95%
PRENTISS SMITH & CO INC 136,441$10,133,0005.74%
MANAGED ASSET PORTFOLIOS, LLC 204,985$15,225,0005.46%
Osher Van de Voorde Investment Management 108,725$8,075,0004.40%
BROWN BROTHERS HARRIMAN & CO 10,796,684$801,870,0004.35%
SECTORAL ASSET MANAGEMENT INC 472,296$35,077,0004.10%
PROFESSIONAL ADVISORY SERVICES INC 235,347$17,479,0003.87%
Elefante Mark B 5,619$417,0003.78%
SPHERA FUNDS MANAGEMENT LTD. 255,000$18,959,0003.71%
CGOV Asset Management 997,161$98,662,0003.61%
View complete list of NOVARTIS A G shareholders